Glenmark Pharma Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20212022
EBITDA2,1352,487
EBIT1,7361,739
Earning Per Share3433
Expenses8,8609,985
Net Profit970994
Net Profit Margin98
Operating Profit Margin2020
Profit Before Tax1,3821,441
Dividends Per Share33
Operation Revenue10,99412,472

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
202298.23103.1086.202,445.2397.80
20221,739.202,486.90993.609,042.131,441.20
2022-1,229.80428.90-1,509.7011,900.64-1,372.50
20223,086.904,252.102,112.2018,985.902,991.10
20224,608.6011,319.203,405.8047,771.294,481.30
The EBITDA of Glenmark Pharma is 2,487 as of 3/23/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities1,6481,3241,3921,1311,109
Investing Activities-1,013-699-784-675-333
Financing Activities-468-739-445-442-520
Others00000
Net Cash Flow166-11416414255

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20221,108.65-333.28-520.49254.88
2022367.311,292.23-1,572.3287.22
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Glenmark Pharma is 1,109 as of 3/23/2023